Naderin

DRUG2 trials

Sponsors

MIPO Clinic

Conditions

Breast CancerChemotherapy-Induced MyelosuppressionHEPATITIS C (HCV)Hematologic DisorderLeukopeniaMalignant NeoplasmsTuberculosis (TB)

Phase 2

Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases

CompletedNCT07671508

MIPO ClinicHEPATITIS C (HCV), Malignant Neoplasms, Tuberculosis (TB)

Start: 2013-05-15End: 2014-03-12Updated: 2026-06-30

Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy

CompletedNCT07671547

MIPO ClinicBreast Cancer, Chemotherapy-Induced Myelosuppression, Hematologic Disorder +1

Start: 2014-01-01End: 2016-12-01Updated: 2026-06-30